<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: Re: Performance enhancement with selegiline</title>
<meta name="Author" content="Alex Ramonsky (alex@ramonsky.com)">
<meta name="Subject" content="Re: Performance enhancement with selegiline">
<meta name="Date" content="2003-02-19">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>Re: Performance enhancement with selegiline</h1>
<!-- received="Wed Feb 19 14:52:30 2003" -->
<!-- isoreceived="20030219215230" -->
<!-- sent="Wed, 19 Feb 2003 21:58:59 +0000" -->
<!-- isosent="20030219215859" -->
<!-- name="Alex Ramonsky" -->
<!-- email="alex@ramonsky.com" -->
<!-- subject="Re: Performance enhancement with selegiline" -->
<!-- id="3E53FE23.10300@ramonsky.com" -->
<!-- charset="us-ascii" -->
<!-- inreplyto="000001c2d81a$1a06d580$324a87d8@MyPC" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Alex Ramonsky (<a href="mailto:alex@ramonsky.com?Subject=Re:%20Performance%20enhancement%20with%20selegiline"><em>alex@ramonsky.com</em></a>)<br>
<strong>Date:</strong> Wed Feb 19 2003 - 14:58:59 MST
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="3121.html">gts: "RE: Performance enhancement with selegiline"</a>
<ul>
<li><strong>Previous message:</strong> <a href="3119.html">Natasha Vita-More: "&quot;Future of Life&quot; Time Magazine - Kurzweil to speak"</a>
<li><strong>In reply to:</strong> <a href="3080.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="3121.html">gts: "RE: Performance enhancement with selegiline"</a>
<li><strong>Reply:</strong> <a href="3121.html">gts: "RE: Performance enhancement with selegiline"</a>
<li><strong>Reply:</strong> <a href="3198.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#3120">[ date ]</a>
<a href="index.html#3120">[ thread ]</a>
<a href="subject.html#3120">[ subject ]</a>
<a href="author.html#3120">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
Measured changes of brain activity in the subject that did not occur 
<br>
before selegiline usage.
<br>
<p>gts wrote:
<br>
<p><em>&gt;Alex Ramonsky wrote:
</em><br>
<em>&gt;
</em><br>
<em>&gt;  
</em><br>
<em>&gt;
</em><br>
<em>&gt;&gt;I have to back this up; our own study reports an increased acuity in
</em><br>
<em>&gt;&gt;both audio and (slightly) visual processing in the subject on
</em><br>
<em>&gt;&gt;Selegiline.. Interestingly, MRI shows increased activity in the
</em><br>
<em>&gt;&gt;temporal lobes when listening to music, but only...get this!...over a
</em><br>
<em>&gt;&gt;certain volume! Ramonsky
</em><br>
<em>&gt;&gt;    
</em><br>
<em>&gt;&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;Interesting. When you write that MRI shows increased activity in the
</em><br>
<em>&gt;temporal lobes when listening to music above a certain volume, are you
</em><br>
<em>&gt;referring specifically to MRI measurements taken of the subject on
</em><br>
<em>&gt;selegiline? Or are you speaking generally?
</em><br>
<em>&gt;
</em><br>
<em>&gt;-gts
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;  
</em><br>
<em>&gt;
</em><br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="3121.html">gts: "RE: Performance enhancement with selegiline"</a>
<li><strong>Previous message:</strong> <a href="3119.html">Natasha Vita-More: "&quot;Future of Life&quot; Time Magazine - Kurzweil to speak"</a>
<li><strong>In reply to:</strong> <a href="3080.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="3121.html">gts: "RE: Performance enhancement with selegiline"</a>
<li><strong>Reply:</strong> <a href="3121.html">gts: "RE: Performance enhancement with selegiline"</a>
<li><strong>Reply:</strong> <a href="3198.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#3120">[ date ]</a>
<a href="index.html#3120">[ thread ]</a>
<a href="subject.html#3120">[ subject ]</a>
<a href="author.html#3120">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Wed Feb 19 2003 - 14:55:25 MST
</em></small></p>
</body>
</html>
